bearish
Austar Lifesciences (6118 HK): It's Risky to Catch the Falling Knife
260 Views22 Jan 2022 22:00
SUMMARY
- Management is not aware of any significant reason for the recent unusual price movement in Austar Lifesciences (6118 HK) shares.
- The company’s strong financial performance in H1 2021 and order book seems to be mostly driven by the COVID-19 vaccine-related demand, which is expected to fade off this year.
- Divestment of its 60% equity interest in Pall-Austar Lifesciences is expected to weaken its competitive positioning in the lifescience tool market in China.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Rising
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- Austar Lifesciences (6118 HK): It's Risky to Catch the Falling Knife22 Jan 2022
x